Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa

Cancer Letters

Volumn 128, Issue 2, 1998, Pages 219-227

  Kataoka, Hiroaki ^a   Uchino, Hirofumi ^a   Denda, Kimitoshi ^b   Kitamura, Naomi ^b   Itoh, Hiroshi ^a   Tsubouchi, Hirohito ^a   Nabeshima, Kazuki ^a   Koono, Masashi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Fac Biosci Biotech   (Japan)

Author keywords

Colon cancer; Hepatocyte growth factor; Hepatocyte growth factor activator; Hepatocyte growth factor activator inhibitor

Indexed keywords

MESSENGER RNA; SCATTER FACTOR; SERINE PROTEINASE INHIBITOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GROWTH; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROSECRETORY CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECTUM; RNA, MESSENGER; TRYPSIN INHIBITOR, KUNITZ SOYBEAN; TUMOR CELLS, CULTURED;

EID: 0032546894     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00067-6     Document Type: Article

References (39)

1. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122:1984;1450-1459.
2. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Miyazaki H., Hashimoto S., Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 81:1988;414-419.
3. Nakamura T., Nawa K., Ichihara A., Kaise N., Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224:1987;311-316.
4. Miyazawa K., Tsubouchi H., Naka D., Takahashi K., Okigaki M., Arakaki N., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Gohda E., Daikuhara Y., Kitamura N. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163:1989;967-973.
5. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:1989;440-443.
6. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
7. Gherardi E., Gray J., Stoker M., Perryman M., Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. USA. 86:1989;5844-5848.
8. Weidner K.M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., Fonatsch C., Tsubouchi H., Hishida T., Daikuhara Y., Birchmeier W. Evidence for the identity of human scatter factor and human growth factor. Proc. Natl. Acad. Sci. USA. 88:1991;7001-7005.
9. Rubin J.S., Bottaro D.P., Aaronson S.A. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim. Biophys. Acta. 1155:1993;357-371.
10. Boros P., Miller C.M. Hepatocyte growth factor: a multifunctional cytokine. Lancet. 345:1995;293-295.
11. Cooper C.S., Park M., Blair D.G., Tainsky M.A., Huebner K., Croce C.M., Vande Woude G.F. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature. 311:1984;29-33.
12. Naldini L., Weidner K.M., Vigna E., Gaudino G., Bardelli A., Ponzetto C., Narsimhan R.P., Hartmann G., Zarnegar R., Micchalopoulos W., Birchmeier W., Comoglio P.M. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 10:1991;2867-2878.
13. Naka D., Ishii T., Yoshiyama Y., Miyazawa K., Hara H., Hishida T., Kitamura N. Activation of hepatocyte growth factor by proteolytic conversion of single chain form to a heterodimer. J. Biol. Chem. 267:1992;20114-20119.
14. Shimomura T., Ochiai M., Kondo J., Morimoto Y. A novel protease obtained from FBS-containing culture supernatant, that processes single-chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology. 8:1992;219-229.
15. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J. Biol. Chem. 268:1993;10024-10028.
16. Shimomura T., Miyazawa K., Komiyama Y., Hiraoka H., Naka D., Morimoto Y., Kitamura N. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur. J. Biochem. 229:1995;257-261.
17. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., Comoglio P.M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11:1992;4825-4833.
18. Mizuno K., Takehara T., Nakamura T. Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease. Biochem. Biophys. Res. Commun. 189:1992;1631-1638.
19. Miyazawa K., Shimomura T., Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J. Biol. Chem. 271:1996;3615-3618.
20. Shimomura T., Kondo J., Ochiai M., Naka D., Miyazawa K., Morimoto Y., Kitamura N. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J. Biol. Chem. 268:1993;22927-22932.
21. Shimomura T., Denda K., Kitamura A., Kawaguchi T., Kito M., Kondo J., Kagaya S., Qin L., Takata H., Miyazawa K., Kitamura N. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:1997;6370-6376.
22. Liu C., Park M., Tsao M.S. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene. 7:1992;181-185.
23. Miyazawa K., Shimomura T., Naka D., Kitamura N. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J. Biol. Chem. 269:1994;8966-8970.
24. Quinn L.A., Moore G.E., Morgan R.T., Woods L.K. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res. 39:1979;4914-4924.
25. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1986;1650-1659.
26. Dvorak H.F., Sioussat T.M., Brown L.F., Berse B., Nagy J.A., Sotrel A., Mansean E.J., Van de Water L., Senger D.R. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 174:1991;1275-1278.
27. Collen D., Verstraete M. Molecular biology of human plasminogen: metabolism in physiological and some pathological conditions in man. Throm. Diath. Haemorrh. 34:1975;403-418.
28. Kinoshita Y., Kishi K., Asahara M., Matsushima Y., Wang H.-Y., Miyazawa K., Kitamura N., Chiba T. Production and activation of hepatocyte growth factor during the healing of rat gastric ulcers. Digestion. 58:1997;225-231.
29. Callander N.S., Varki N., Rao V.M. Immunohistochemical identification of tissue factor in solid tumors. Cancer. 70:1992;1194-1201.
30. Kataoka H., Uchino H., Asada Y., Hatakeyama K., Nabeshima K., Sumiyoshi A., Koono M. Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver. Int. J. Cancer. 72:1997;878-884.
31. Bellusci S., Moens G., Gaudino G., Comoglio P., Nakamura T., Thiery J.-P., Jouanneau J. Creation of a hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene. 9:1994;1091-1099.
32. Rong S., Segal S., Anver M., Resau J.H., Vande Woude G.F. Invasiveness and metastasis of NIH3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA. 91:1994;4731-4735.
33. Matsumoto K., Date K., Shimura H., Nakamura T. Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor. Jpn. J. Cancer Res. 87:1996;702-710.
34. Iwazawa T., Shiozaki H., Doki Y., Inoue M., Tamura S., Matsui S., Monden T., Matsumoto K., Nakamura T., Monden M. Primary human fibroblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor. Jpn. J. Cancer Res. 87:1996;1134-1142.
35. Nakamura T., Matsumoto K., Kiritoshi A., Tano Y., Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57:1997;3305-3313.
36. Seslar S.P., Nakamura T., Byers S.W. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res. 53:1993;1233-1238.
37. Naldini L., Vigna E., Bardelli A., Follenzi A., Galimi F., Comoglio P.M. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J. Biol. Chem. 270:1995;603-611.
38. Pyke C., Kristensen P., Ralfkiaer E., Grondahl-Hansen J., Eriksen J., Blasi F., Dano K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Pathol. 138:1991;1059-1067.
39. Kawaguchi T., Qin L., Shimomura T., Kondo J., Matsumoto K., Denda K., Kitamura N. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:1997;27558-27564.